Fiscal Period | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Period End Date | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
Net Income/ Starting Line | 9,408.43 | 4,481.32 | 2,799.37 | 5,009.59 |
Depreciation/ Depletion | 2,529.43 | 2,143.74 | 2,079.95 | 2,052.78 |
Non- Cash Items | 193.13 | -168.79 | -270.10 | -60.24 |
Changesin Working Capital | -6,604.97 | 2,569.72 | 1,561.15 | -447.36 |
Cashfrom Operating Activities | 5,526.02 | 9,025.99 | 6,170.37 | 6,554.77 |
Capital Expenditures | -2,085.58 | -1,495.04 | -1,170.13 | -1,542.00 |
Other Investing Cash Flow Items Total | -5,858.10 | -4,229.70 | 1,706.35 | -1,046.84 |
Cashfrom Investing Activities | -7,943.68 | -5,724.74 | 536.22 | -2,588.84 |
Financing Cash Flow Items | -100.09 | -269.18 | 68.63 | -1,212.96 |
Total Cash Dividends Paid | -2,518.88 | -2,158.92 | -1,559.47 | -1,379.19 |
Issuance( Retirement)of Debt Net | 4,995.04 | -2,765.36 | -4,489.64 | -3,122.99 |
Cashfrom Financing Activities | 2,376.07 | -5,193.46 | -5,980.48 | -5,715.14 |
Foreign Exchange Effects | 157.07 | 127.43 | -129.69 | 363.52 |
Net Changein Cash | 115.48 | -1,764.78 | 596.42 | -1,385.69 |
Cash Interest Paid | 99.24 | 73.21 | 144.25 | 271.89 |
Cash Taxes Paid | 1,509.84 | -969.22 | 1,002.94 | 1,345.91 |
Issuance( Retirement)of Stock Net | - | - | - | 0.00 |
Sun Pharmaceutical Industries Dividend | Sun Pharmaceutical Industries Bonus | Sun Pharmaceutical Industries News | Sun Pharmaceutical Industries AGM | Sun Pharmaceutical Industries Rights | Sun Pharmaceutical Industries Splits | Sun Pharmaceutical Industries Board Meetings | Sun Pharmaceutical Industries Key Metrics | Sun Pharmaceutical Industries Shareholdings | Sun Pharmaceutical Industries Profit Loss | Sun Pharmaceutical Industries Balance Sheet | Sun Pharmaceutical Industries Q1 Results | Sun Pharmaceutical Industries Q2 Results | Sun Pharmaceutical Industries Q3 Results | Sun Pharmaceutical Industries Q4 Results
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks